KIR3DL1 and HLA-B subtype combinations predict the efficacy of 3F8 monoclonal antibody therapy for neuroblastoma Meeting Abstract
| Authors: | Forlenza, C. J.; Boudreau, J. E.; Zheng, J.; Heller, G.; Cheung, N. K. V.; Hsu, K. C. |
| Abstract Title: | KIR3DL1 and HLA-B subtype combinations predict the efficacy of 3F8 monoclonal antibody therapy for neuroblastoma |
| Meeting Title: | 106th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 75 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 Apr 18-22 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2015-08-01 |
| Language: | English |
| ACCESSION: | WOS:000371578505060 |
| DOI: | 10.1158/1538-7445.am2015-2459 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2459 -- Proceedings of the 106th Annual Meeting of the American Association for Cancer Research -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work